Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
2
100%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
2(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Completed(1)
Terminated(1)

Detailed Status

Completed1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 42 (100.0%)

Trials by Status

completed150%
withdrawn150%

Recent Activity

0 active trials
Showing 2 of 2
withdrawnphase_4

Proton Pump Inhibitors Use in Patients With Psoriasis

NCT02624544
completedphase_4

Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

NCT01542138

Clinical Trials (2)

Showing 2 of 2 trials
NCT02624544Phase 4

Proton Pump Inhibitors Use in Patients With Psoriasis

Withdrawn
NCT01542138Phase 4

Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

Completed

All 2 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
2